Lewiecki, E Michael <br/><br/>
RANK ligand inhibition with denosumab for the management of osteoporosis.  [electronic resource] 

 -  Expert opinion on biological therapy  Oct 2006 
 - 1041-50 p.  digital 
<br/><br/> Publication Type: Journal Article; Review 
<br/><br/><label>ISSN: </label>1744-7682 
<br/><br/><label>Standard No.: </label>10.1517/14712598.6.10.1041  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antibodies, Monoclonal--therapeutic use<br/>Antibodies, Monoclonal, Humanized<br/>Denosumab<br/>Disease Management<br/>Humans<br/>Osteoporosis--immunology<br/>RANK Ligand--antagonists & inhibitors